Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dentistry
Volume 2015 (2015), Article ID 831418, 3 pages
http://dx.doi.org/10.1155/2015/831418
Case Report

Oral Squamous Cell Carcinoma Arising in a Patient after Hematopoietic Stem Cell Transplantation with Bisphosphonate-Related Osteonecrosis of the Jaws

1Department of Surgical Sciences, Oral Medicine Section, CIR Dental School, University of Turin, Via Nizza 230, 10126 Turin, Italy
2WHO Collaborating Centre for Oral Health-General Health, UK
3University College London, Gower Street, London WC1E 6BT, UK
4Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Corso Bramante 88, 10126 Turin, Italy

Received 3 February 2015; Accepted 1 April 2015

Academic Editor: Pia Lopez Jornet

Copyright © 2015 Paolo G. Arduino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Ruggiero and B. Mehrotra, “Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management,” Annual Review of Medicine, vol. 60, pp. 85–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. L. Ruggiero, T. B. Dodson, J. Fantasia et al., “American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update,” Journal of Oral and Maxillofacial Surgery, vol. 72, no. 10, pp. 1938–1956, 2014. View at Publisher · View at Google Scholar
  3. I. R. Reid, M. J. Bolland, and A. B. Grey, “Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?” Bone, vol. 41, no. 3, pp. 318–320, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. H. Lin, “Bisphosphonates: a review of their pharmacokinetic properties,” Bone, vol. 18, no. 2, pp. 75–85, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Giraudo, M. Inoue, and D. Hanahan, “An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis,” The Journal of Clinical Investigation, vol. 114, no. 5, pp. 623–633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Montague, C. A. Hart, N. J. George, V. A. C. Ramani, M. D. Brown, and N. W. Clarke, “Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of zoledronic acid in prostate cancer,” European Urology, vol. 46, no. 3, pp. 389–402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ali-Erdem, A. Burak-Cankaya, S. Cemil-Isler et al., “Extraction socket healing in rats treated with bisphosphonate: animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 16, no. 7, pp. e879–e883, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Kikuiri, I. Kim, T. Yamaza et al., “Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice,” Journal of Bone and Mineral Research, vol. 25, no. 7, pp. 1668–1679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Scoletta, P. G. Arduino, P. Dalmasso, R. Broccoletti, and M. Mozzati, “Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 110, no. 1, pp. 46–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. T. M. Haverman, J. E. Raber-Durlacher, W. M. H. Rademacher et al., “Oral complications in hematopoietic stem cell recipients: the role of inflammation,” Mediators of Inflammation, vol. 2014, Article ID 378281, 18 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C.-K. Chung, R. K.-Y. Tsang, V. S.-H. To et al., “Secondary head and neck cancer in patients with history of hematological malignancy,” Head & Neck, vol. 35, no. 5, pp. 729–732, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Atsuta, R. Suzuki, T. Yamashita et al., “Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease,” Annals of Oncology, vol. 25, no. 2, pp. 435–441, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. R. E. Curtis, P. A. Rowlings, H. J. Deeg et al., “Solid cancers after bone marrow transplantation,” The New England Journal of Medicine, vol. 336, no. 13, pp. 897–904, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Mawardi, S. Elad, M. E. Correa et al., “Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes,” Bone Marrow Transplantation, vol. 46, no. 6, pp. 884–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. L. Kruse and K. W. Grätz, “Oral carcinoma after hematopoietic stem cell transplantation—a new classification based on a literature review over 30 years,” Head & Neck Oncology, vol. 1, article 29, 2009. View at Publisher · View at Google Scholar
  16. R. L. F. de Araújo, K. D. F. Lyko, V. A. M. Funke, and C. C. Torres-Pereira, “Oral cancer after prolonged immunosuppression for multiorgan chronic graft-versus-host disease,” Revista Brasileira de Hematologia e Hemoterapia, vol. 36, no. 1, pp. 65–68, 2014. View at Publisher · View at Google Scholar · View at Scopus